An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Treatment Acquiring Popularity Online
The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these accounts privately for source information, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Worries
Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in users administering substances of unknown origin.
Some experts said the popularity for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.
Some influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment.
Platform Response and Content Elimination
Based on the social media company, the service has removed violative material and banned associated hashtags and search suggestions. The organization said it was committed to keeping the service secure and investing in strengthening compliance measures.
Online Marketplace Operations
Research also discovered groups with up to 9,000 members selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of users, populated with photos of weight loss, positive testimonials and step-by-step guides for preparing or administering at home.
Within minutes of joining one group, a vendor posted contact information, where most transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.
Item Information and Pricing
Inside these groups, messages show dark colored packages with Royal Mail stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how long a injector should last, vendors give conflicting responses varying between a several days to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for Telegram said it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering materials they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her team has previously seen individuals harmed by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational product not yet authorized … may subject users to potentially significant medical dangers”.
